253 related articles for article (PubMed ID: 30099335)
21. Precise and efficient scarless genome editing in stem cells using CORRECT.
Kwart D; Paquet D; Teo S; Tessier-Lavigne M
Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
Meng G; Liu S; Rancourt DE
Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
[TBL] [Abstract][Full Text] [Related]
23. A Method to Map Gene Essentiality of Human Pluripotent Stem Cells by Genome-Scale CRISPR Screens with Inducible Cas9.
Mair B; Aregger M; Tong AHY; Chan KSK; Moffat J
Methods Mol Biol; 2022; 2377():1-27. PubMed ID: 34709608
[TBL] [Abstract][Full Text] [Related]
24. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
25. Gene Editing and Human Pluripotent Stem Cells: Tools for Advancing Diabetes Disease Modeling and Beta-Cell Development.
Millette K; Georgia S
Curr Diab Rep; 2017 Oct; 17(11):116. PubMed ID: 28980194
[TBL] [Abstract][Full Text] [Related]
26. Bio-inspired oligovitronectin-grafted surface for enhanced self-renewal and long-term maintenance of human pluripotent stem cells under feeder-free conditions.
Park HJ; Yang K; Kim MJ; Jang J; Lee M; Kim DW; Lee H; Cho SW
Biomaterials; 2015 May; 50():127-39. PubMed ID: 25736503
[TBL] [Abstract][Full Text] [Related]
27. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
28. Modulation of Wnt and Activin/Nodal supports efficient derivation, cloning and suspension expansion of human pluripotent stem cells.
Ai Z; Niu B; Duan K; Si C; Wang S; Xiang L; Zhu X; Zhu Q; Feng C; Yin Y; Zhao S; Kong R; Ji W; Li T
Biomaterials; 2020 Aug; 249():120015. PubMed ID: 32311594
[TBL] [Abstract][Full Text] [Related]
29. A simple and efficient cryopreservation method for feeder-free dissociated human induced pluripotent stem cells and human embryonic stem cells.
Mollamohammadi S; Taei A; Pakzad M; Totonchi M; Seifinejad A; Masoudi N; Baharvand H
Hum Reprod; 2009 Oct; 24(10):2468-76. PubMed ID: 19602515
[TBL] [Abstract][Full Text] [Related]
30. Genome-Scale CRISPR Screens Identify Human Pluripotency-Specific Genes.
Ihry RJ; Salick MR; Ho DJ; Sondey M; Kommineni S; Paula S; Raymond J; Henry B; Frias E; Wang Q; Worringer KA; Ye C; Russ C; Reece-Hoyes JS; Altshuler RC; Randhawa R; Yang Z; McAllister G; Hoffman GR; Dolmetsch R; Kaykas A
Cell Rep; 2019 Apr; 27(2):616-630.e6. PubMed ID: 30970262
[TBL] [Abstract][Full Text] [Related]
31. Genome editing in human pluripotent stem cells using site-specific nucleases.
Chiba K; Hockemeyer D
Methods Mol Biol; 2015; 1239():267-80. PubMed ID: 25408412
[TBL] [Abstract][Full Text] [Related]
32. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
[TBL] [Abstract][Full Text] [Related]
33. Xeno- and feeder-free differentiation of human pluripotent stem cells to two distinct ocular epithelial cell types using simple modifications of one method.
Hongisto H; Ilmarinen T; Vattulainen M; Mikhailova A; Skottman H
Stem Cell Res Ther; 2017 Dec; 8(1):291. PubMed ID: 29284513
[TBL] [Abstract][Full Text] [Related]
34. Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards.
Martin RM; Fowler JL; Cromer MK; Lesch BJ; Ponce E; Uchida N; Nishimura T; Porteus MH; Loh KM
Nat Commun; 2020 Jun; 11(1):2713. PubMed ID: 32483127
[TBL] [Abstract][Full Text] [Related]
35. Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies.
Mair B; Tomic J; Masud SN; Tonge P; Weiss A; Usaj M; Tong AHY; Kwan JJ; Brown KR; Titus E; Atkins M; Chan KSK; Munsie L; Habsid A; Han H; Kennedy M; Cohen B; Keller G; Moffat J
Cell Rep; 2019 Apr; 27(2):599-615.e12. PubMed ID: 30970261
[TBL] [Abstract][Full Text] [Related]
36. Manipulating and studying gene function in human pluripotent stem cell models.
Balmas E; Sozza F; Bottini S; Ratto ML; Savorè G; Becca S; Snijders KE; Bertero A
FEBS Lett; 2023 Sep; 597(18):2250-2287. PubMed ID: 37519013
[TBL] [Abstract][Full Text] [Related]
37. Efficient and safe single-cell cloning of human pluripotent stem cells using the CEPT cocktail.
Tristan CA; Hong H; Jethmalani Y; Chen Y; Weber C; Chu PH; Ryu S; Jovanovic VM; Hur I; Voss TC; Simeonov A; Singeç I
Nat Protoc; 2023 Jan; 18(1):58-80. PubMed ID: 36261632
[TBL] [Abstract][Full Text] [Related]
38. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
Horii T; Hatada I
Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
40. An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells.
Xie Y; Wang D; Lan F; Wei G; Ni T; Chai R; Liu D; Hu S; Li M; Li D; Wang H; Wang Y
Sci Rep; 2017 May; 7(1):2320. PubMed ID: 28539611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
